The β
Humans
Th17 Cells
/ immunology
Nebivolol
/ pharmacology
Adrenergic beta-2 Receptor Agonists
/ pharmacology
Immunologic Memory
/ drug effects
NF-kappa B
/ metabolism
Receptors, Adrenergic, beta-2
/ metabolism
Signal Transduction
/ drug effects
Interleukin-17
/ metabolism
Cells, Cultured
Cell Differentiation
/ drug effects
IL-17A
NF-κB activation
Th17 cells
anti-inflammatory response
beta-adrenergic receptor
biased agonist
nebivolol
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
09
06
2024
accepted:
11
09
2024
medline:
24
10
2024
pubmed:
24
10
2024
entrez:
24
10
2024
Statut:
epublish
Résumé
Adrenergic receptors regulate metabolic, cardiovascular, and immunological functions in response to the sympathetic nervous system. The effect of β The effects of nebivolol were tested on healthy human peripheral blood mononuclear cells, purified memory Th cells, and polarized naive Th17 cells activated with anti-CD3/anti-CD28/anti-CD2 ImmunoCult reagent. IFN-γ, IL-4, and IL-17A, which are primarily derived from Th1, Th2, and Th17 cells, respectively, were quantified by ELISA and flow cytometry. IL-10 was measured by ELISA. Gene expression of RORC, ADRB1, ADRB2, and ADRB3 was evaluated by qPCR. The ADRB2 gene was knocked out in memory Th cells using CRISPR/Cas9. Protein expression of phosphorylated serine133-CREB and phosphorylated NF-κB p65 was assessed by Western blot. Proliferation was assessed by fluorescent dye loading and flow cytometry. Nebivolol treatment decreased IL-17A and IFN-γ secretion by activated memory Th cells and elevated IL-4 levels. Nebivolol reduced the proportion of IL-17A The findings demonstrate that nebivolol acts through a β
Identifiants
pubmed: 39445009
doi: 10.3389/fimmu.2024.1446424
pmc: PMC11496295
doi:
Substances chimiques
Nebivolol
030Y90569U
Adrenergic beta-2 Receptor Agonists
0
NF-kappa B
0
Receptors, Adrenergic, beta-2
0
Interleukin-17
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1446424Informations de copyright
Copyright © 2024 Hajiaghayi, Gholizadeh, Han, Little, Rahbari, Ardila, Lopez Naranjo, Tehranimeh, Shih and Darlington.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.